GMXRX
Price
$16.33
Change
-$0.18 (-1.09%)
Updated
Sep 9 closing price
Net Assets
480.14M
VMCIX
Price
$88.77
Change
-$0.72 (-0.80%)
Updated
Sep 9 closing price
Net Assets
226.38B
Interact to see
Advertisement

GMXRX vs VMCIX

GMXRX vs VMCIX Comparison Chart in %
View a ticker or compare two or three
VS
GMXRX vs. VMCIX commentary
Sep 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMXRX is a Buy and VMCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCIX has more cash in the bank: 226B vs. GMXRX (480M). VMCIX pays higher dividends than GMXRX: VMCIX (1.30) vs GMXRX (0.40). GMXRX was incepted earlier than VMCIX: GMXRX (20 years) vs VMCIX (28 years). GMXRX (1.03) is less costly to investors than VMCIX (0.03). VMCIX (16.00) and GMXRX (15.69) have comparable annual turnover. GMXRX has a lower initial minimum investment than VMCIX: GMXRX (0) vs VMCIX (5000000). VMCIX annual gain was more profitable for investors over the last year : 13.04 vs. GMXRX (2.55). VMCIX return over 5 years is better than : 34.92 vs. GMXRX (-11.27).
GMXRXVMCIXGMXRX / VMCIX
Total Expense Ratio1.000.033,333%
Annual Report Gross Expense Ratio1.030.033,433%
Fund Existence20 years28 years-
Gain YTD14.81212.822116%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets480M226B0%
Annual Yield % from dividends0.401.3031%
Returns for 1 year2.5513.0420%
Returns for 3 years12.7551.7525%
Returns for 5 years-11.2734.92-32%
Returns for 10 years2.55163.452%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RCUS29.06-0.60
-2.02%
Arcus Biosciences
MNPR114.38-3.18
-2.71%
Monopar Therapeutics Inc
CODX1.12-0.04
-3.45%
Co-Diagnostics Inc.
MED12.16-0.47
-3.72%
Medifast
CTSH59.92-2.39
-3.84%
Cognizant Technology Solutions Corp